Gold prices slip lower; consolidating after recent gains
Investing.com - Astrana Health (NASDAQ: ASTH) reported second quarter EPS of $0.40, $0.01 better than the analyst estimate of $0.39. Revenue for the quarter came in at $486.3M versus the consensus estimate of $440.74M.
Guidance
Astrana Health sees FY 2024 EPS of $1.12-$1.36 versus the analyst consensus of $2.13.
Astrana Health sees FY 2024 revenue of $1.75B-$1.85B versus the analyst consensus of $1.76B.
Astrana Health's stock price closed at $46.36. It is up 19.21% in the last 3 months and up 18.11% in the last 12 months.
Astrana Health saw 1 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See Astrana Health's stock price’s past reactions to earnings here.
According to InvestingPro, Astrana Health's Financial Health score is "great performance".
Check out Astrana Health's recent earnings performance, and Astrana Health's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar